BioSpace News Archive

Company further sharpens focus on patient access to innovative medicines in Latin America

DENTSPLY SIRONA Inc., The Dental Solutions Company, announced its financial results for the three and twelve months ended December 31, 2019.

Zhongchao Inc. announced that Network 1 Financial Securities, Inc., who acted as the lead underwriter and bookrunner of the Company’s initial public offering, has partially exercised their over-allotment option and purchased an additional 315,003 Class A ordinary shares at the IPO price of $4.00 per share.

Mallinckrodt plc (NYSE: MNK), a global biopharmaceutical company, today announced it initiated the rolling submission of a New Drug Application (NDA) to the U.S. Food and Drug Administration (FDA) for terlipressin, an investigational agent being investigated for the treatment of hepatorenal syndrome type 1 (HRS-1), by submitting its clinical data package

BioXcel Therapeutics, Inc. (“BTI” or “Company”) (Nasdaq: BTAI), a clinical-stage biopharmaceutical company utilizing artificial intelligence to identify improved therapies in neuroscience and immuno-oncology, today announced it will host a conference call and webcast on Monday, March 9, 2020 at 8:30 AM Eastern Time to discuss its fourth quarter and full year 2019 operating and financial results.